Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery Whi

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurocritical Care

• Publication date

  2018-07-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12028-018-0575-zPMID 30014184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of External Ventricular Drains After Subarachnoid Hemorrhage: A Multi-Institutional Survey

  2017cited by this paper
• Spontaneous subarachnoid haemorrhage.

  2017cited by this paper
• Randomized , Open-Label , Phase 1 / 2 a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage ( NEWTON [ Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage

  2016cited by this paper
• A Site-Specific, Sustained-Release Drug Delivery System for Aneurysmal Subarachnoid Hemorrhage

  2016cited by this paper
• Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage

  2016cited by this paper
• Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])

  2016cited by this paper
• The Glasgow Outcome Scale — 40 years of application and refinement

  2016cited by this paper
• Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage

  2015cited by this paper
• Intrathecal application of the nimodipine slow-release microparticle system eg-1962 for prevention of delayed cerebral ischemia and improvement of outcome after aneurysmal subarachnoid hemorrhage.

  2015cited by this paper
• NEWTON: Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage

  2015cited by this paper
• The Glasgow Coma Scale at 40 years: standing the test of time.

  2014cited by this paper
• Delayed neurological deterioration after subarachnoid haemorrhage

  2014cited by this paper
• How we do it: acute management of subarachnoid hemorrhage

  2013cited by this paper
• SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

  2013cited by this paper
• The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage

  2013cited by this paper
• Current Options for the Management of Aneurysmal Subarachnoid Hemorrhage-Induced Cerebral Vasospasm: A Comprehensive Review of the Literature

  2013cited by this paper
• Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

  2012cited by this paper
• Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

  2012cited by this paper
• Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

  2012cited by this paper
• Intraventricular Nicardipine for Aneurysmal Subarachnoid Hemorrhage Related Vasospasm: Assessment of 90 Days Outcome

  2012cited by this paper
• Impairment of Cerebral Autoregulation Predicts Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: A Prospective Observational Study

  2012cited by this paper
• The importance of early brain injury after subarachnoid hemorrhage.

  2012cited by this paper
• Interobserver Variability of Grading Scales for Aneurysmal Subarachnoid Hemorrhage

  2011cited by this paper
• High-Dose Intra-Arterial Nicardipine Results in Hypotension Following Vasospasm Treatment in Subarachnoid Hemorrhage

  2011cited by this paper
• Critical Care Management of Patients Following Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference

  2011cited by this paper
• Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage.

  2010cited by this paper
• Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies: Proposal of a Multidisciplinary Research Group

  2010cited by this paper
• Intensive care of aneurysmal subarachnoid hemorrhage: an international survey

  2009cited by this paper
• Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage

  2009cited by this paper
• Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis.

  2009cited by this paper
• Calcium Antagonists for Aneurysmal Subarachnoid Hemorrhage

  2008cited by this paper
• Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.

  2008cited by this paper
• Calcium antagonists for aneurysmal subarachnoid haemorrhage.

  2007cited by this paper
• Effect of Nicardipine Prolonged-Release Implants on Cerebral Vasospasm and Clinical Outcome After Severe Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized, Double-Blind Phase IIa Study

  2007cited by this paper
• Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.

  2006cited by this paper
• Application of Nicardipine Prolonged-release Implants.

  2006cited by this paper
• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment

  2005cited by this paper
• Application of Nicardipine Prolonged-release Implants: Analysis of 97 Consecutive Patients with Acute Subarachnoid Hemorrhage

  2005cited by this paper
• Calcium Antagonists in Aneurysmal Subarachnoid Hemorrhage

  2005cited by this paper
• Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage

  2005cited by this paper
• Cost-Effective Outcome for Treating Poor-Grade Subarachnoid Hemorrhage

  2003cited by this paper
• Blinding in randomised trials: hiding who got what.

  2002cited by this paper
• Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their Use

  1998cited by this paper
• Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

  1988cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale.

  1988cited by this paper
• Cerebral artery spasm — A controlled trial of nimodipine in patients with subarachnoid hemorrhage: Allen GS, Ahn HS, Preziosi TJ, et al N Engl J Med 308:619–624 Mar 1983

  1983cited by this paper
• Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

  1983cited by this paper
• Blinding in randomised trials : hiding who got what

  year unknowncited by this paper

• Nimodipine dosing and pharmacokinetic variability in subarachnoid hemorrhage patients.

  2026cites this paper
• Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood–Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery

  2024cites this paper
• Nimodipine prophylaxis in aneurysmal subarachnoid hemorrhage, a question of tradition or evidence: A scoping review.

  2024cites this paper
• Blood Pressure Changes in Association with Nimodipine Therapy in Patients with Spontaneous Subarachnoid Hemorrhage

  2023cites this paper
• The Local Intraarterial Administration of Nimodipine Might Positively Affect Clinical Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage and Delayed Cerebral Ischemia

  2022cites this paper
• PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases

  2022cites this paper
• Harnessing Cerebrospinal Fluid Circulation for Drug Delivery to Brain Tissues.

  2021cites this paper
• Essentials of nimodipine in neurocritical care patients

  2021cites this paper
• Safety and efficacy of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage induced vasospasm

  2021cites this paper
• Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm

  2021cites this paper
• Delayed hospital admission of patients with aneurysmal subarachnoid hemorrhage: clinical presentation, treatment strategies, and outcome.

  2020cites this paper
• Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  2020cites this paper
• Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage

  2020cites this paper
• Single-Dose Intraventricular Nimodipine Microparticles Versus Oral Nimodipine for Aneurysmal Subarachnoid Hemorrhage

  2020cites this paper
• Intrathecal drug delivery in the era of nanomedicine.

  2020cites this paper
• Management of Patient with Aneurysmal Subarachnoid Hemorrhage

  2020cites this paper
• The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies

  2020cites this paper
• NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.

  2020cites this paper
• Commentary: Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage Is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction.

  2020cites this paper
• De ning Optimal Dosing of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Study Protocol for a Systematic Review

  2020cites this paper
• MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats

  2019cites this paper
• Clinical and experimental aspects of aneurysmal subarachnoid hemorrhage

  2019cites this paper
• Nimodipine Reappraised: An Old Drug with a Future

  2019cites this paper
• The role of haptoglobin and hemopexin in the prevention of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a review of current literature

  2019cites this paper
• Aneurysmal Subarachnoid Hemorrhage and Resolution of Inflammation

  2019cites this paper
• Incidence of Arterial Hypotension in Patients Receiving Peroral or Continuous Intra-arterial Nimodipine After Aneurysmal or Perimesencephalic Subarachnoid Hemorrhage

  2019cites this paper
• Intracranial Administration of Nicardipine After Aneurysmal Subarachnoid Hemorrhage: A Review of the Literature.

  2019cites this paper
• The expression of cerebrospinal fluid exosomal miR-630 plays an important role in the dysfunction of endothelial cells after subarachnoid hemorrhage

  2019cites this paper
• Early clinical course after aneurysmal subarachnoid hemorrhage: comparison of patients treated with Woven EndoBridge, microsurgical clipping, or endovascular coiling

  2019cites this paper
• Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome

  2019cites this paper
• Nanoparticle-Facilitated Delivery of Antioxidant Therapy following Aneurysmal Subarachnoid Hemorrhage.

  2019cites this paper